Featured/ PEN/ 01/15/2026 · 7:14 AM Boston Scientific to Acquire Penumbra in $14.5 Billion Deal Boston Scientific announces acquisition of Penumbra for $14.5B, expanding into blood clot removal and neurovascular treatments to address cardiovascular diseases.